FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099023 [Registered on: 12/12/2025] Trial Registered Prospectively
Last Modified On: 13/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Evaluating the effectiveness of Manjishtadi Taila in treating first and second degree burns.  
Scientific Title of Study   A randomized controlled clinical trial to evaluate the efficacy of Manjishtadi Tail in Durdagdha with special reference to first and second degree burn. 
Trial Acronym  Not Applicable  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ganesh Vaijnath Chavan  
Designation  M.S Scholar Shalyatantra Samanya  
Affiliation  Shree Saptashrungi ayurvedic mahavidyalaya  
Address  Department of Shalyatantra Samanya Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia Nashik MAHARASHTRA 422003 India

Nashik
MAHARASHTRA
422003
India 
Phone  07038497623  
Fax    
Email  chavanganesh105@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ramesh Ahire  
Designation  Professor Shalyatantra Department  
Affiliation  Shree Saptashrungi ayurvedic mahavidyalaya 
Address  Department of Shalyatantra Samanya Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia Nashik MAHARASHTRA 422003 India

Nashik
MAHARASHTRA
422003
India 
Phone  9623843106  
Fax    
Email  ramesh.v.ahire@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ganesh Vaijnath Chavan 
Designation  M.S Scholar Shalyatantra Samanya 
Affiliation  Shree Saptashrungi ayurvedic mahavidyalaya 
Address  Department of Shalyatantra Samanya Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia Nashik MAHARASHTRA 422003 India

Nashik
MAHARASHTRA
422003
India 
Phone  07038497623  
Fax    
Email  chavanganesh105@gmail.com  
 
Source of Monetary or Material Support  
Department of Shalyatantra Samanya OPD no. 3 Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia 
 
Primary Sponsor  
Name  Department of Shalyatantra Samanya Shree saptashrungi Ayurved Mahavidyalaya 
Address  Department of Shalyatantra Samanya OPD no. 3 Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ganesh Chavan   Department of Shalyatantra Samanya Shree saptashrungi Ayurved Mahavidyalaya and hospital  Department of Shalyatantra Samanya OPD no. 3 Shree saptashrungi Ayurved Mahavidyalaya Kamal Nagar Hirawadi Panchvati Nashik Maharashtra 422003I ndia
Nashik
MAHARASHTRA 
07038497623

chavanganesh105@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Shree saptashrungi Ayurved Mahavidyalaya Nashik Panchavati Maharashtra422003  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L99||Other disorders of skin and subcutaneous tissue in diseases classified elsewhere. Ayurveda Condition: DAGDHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Silver sulphadiazine Local application over burned area
2Intervention ArmDrugClassical(1) Medicine Name: Manjishthadi taila, Reference: Bahaishajya ratnavali 48/20, Route: Topical, Dosage Form: Taila, Dose: 10(g), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 21 Days, Reference: No, Route: -, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
3Intervention ArmDrugClassical(1) Medicine Name: Manjishthadi taila, Reference: Bahaishajya ratnavali 48/20, Route: Topical, Dosage Form: Taila, Dose: 10(g), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 21 Days, Reference: No, Route: -, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Clinical assessment for durdagdha associated with burn  
 
ExclusionCriteria 
Details  1.Third Degree Burn
2.fourth degree Burn
3.Patient with Any comorbidities
4. Burn over Genital Area
5. Burn over facial parts  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Controlled clinical study to assess the efficacy of Manjistadi tail in the
management of durdagdha w.s.r to 1° and 2° burn.qq 
21 days 
 
Secondary Outcome  
Outcome  TimePoints 
Where the trial group stands in comparison with control group  12 months 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   14/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title - A Randomized controlled clinical trial to evaluate efficacy of manjishthadi taila in Durdagdha with special reference to first and second degree Burn
Primary Objective -Controlled clinicalstudy to assess efficacy of Manjishthadi taila in the management of Durdagdha w.r.t First degree second degree Burn 

Secondary Objective - 
1. To study the first and second degree Burn and Durdagdha as per ayurvedic and modern conect 
2. To study about Manjishta

STUDY DESIGN  - Randomized controlled clinical trial 
Group A( trial group) -  Manjishthadi taila 
Group B (control Group)- 1 percentage Silver sulphadiazine 
Assessment 0,7,14,21 th Day 
Sample size- 62  , each group 31 

Data analysis 
Data will be analysed using appropriate statistical methods to compare the effectiveness of intervention on the primary and secondary outcomes.

Ethical Consideration -
The study will be conducted in accordance with Ethical Guidelines and with informed consent from participants.





 
Close